VEGF, IVF clinical variables and ovarian hyperstimulation syndrome: A prospective study of the preimplantation luteal phase

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 5, 2007, Pages 365-374

  Kung, Fu Tsai ^a,b   Chang, Shiuh Young ^a   Huang, Fu Jen ^a   Lan, Kuo Chung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

In vitro fertilization; Infertility, female; Ovarian hyperstimulation syndrome; Vascular endothelial growth factors

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LEUPRORELIN; PROGESTERONE; VASCULOTROPIN;

ADULT; ARTICLE; CORRELATION ANALYSIS; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PERITONEAL FLUID; PREGNANCY OUTCOME; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; ASCITIC FLUID; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEAL PHASE; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34249079391     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ferrara N, Houck K, Jakeman L, et al: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol Rev 1992;13:18-32
2. Torry DS, Torry RJ: Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol 1997;37:21-29
3. Geva E, Jaffe RB: Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000;74: 429-438
4. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocrinol Rev 1997;18:4-25
5. Smith SK: Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update 1998;4:509-519
6. Ratcliffe KE, Anthony FW, Richardson MC, et al: Morphology and functional characteristics of human ovarian microvascular endothelium. Hum Reprod 1999;14:1549-1554
7. Sugino N, Kashida S, Karube-Harada A, et al: Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 2002;123:379-387
8. Krussel J, Behr B, Hirchenhain J, et al: Expression of vascular endothelial growth factor mRNA in human preimplantation embryos derived from tripronuclear zygotes. Fertil Steril 2000;74:1220-1226
9. McClure N, Healy DL, Rogers PA, et al: Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235-236
10. Neulen J, Yan Z, Raczek S, et al: Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967-1971
11. Pellicer A, Albert C, Mercader A, et al: The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1 beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril 1999;71:482-489
12. Agrawal R, Tan SL, Wild S, et al: Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 1999;71:287-293
13. Ludwig M, Jelkmann W, Bauer O, et al: Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 1999;14:2437-2441
14. Wang TH, Horng SG, Chang CL, et al: Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 2002;87:3300-3308
15. Mathur R, Hayman G, Bansal A, et al: Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception. Fertil Steril 2002;78:1154-1158
16. Agrawal R, Jacobs H, Payne N, et al: Concentration of vascular endothelial growth factor released by cultured luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 2002;78:1164-1169
17. Tsai MY, Huang FJ, Kung FT, et al: Influence of polyvinyl-pyrrolidone on the outcome of intracytoplasmic sperm injection. J Reprod Med 2000;45:115-120
18. Kung FT, Lin YC, Tseng YJ, et al: Transfer of frozen-thawed blastocysts that underwent quarter laser-assisted hatching at the day 3 cleaving stage before freezing. Fertil Steril 2003; 79:893-899
19. Kung FT, Chang SY, Yang CY, et al: Transfer of non-selected transferable day-3 embryos in low embryo producers. Fertil Steril 2004;80:1364-1370
20. Golan A, Ron-El A, Hesman A, et al: Ovarian hyperstimulation syndrome: An update review. Obstet Gynecol Surv 1989;44:430-440
21. Artini PG, Monti M, Fasciani A, et al: Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilization. Gynecol Endocrinol 1998;12:143-147
22. Licht P, Neuwinger J, Fischer O, et al: Peripheral levels of vascular endothelial growth factor (VEGF) are higher in gonadotropin stimulated as compared to natural ovarian cycles. Exp Clin Endocrinol Diabetes 2001;109:345-349
23. Enskog A, Nilsson L, Brannstrom M: Plasma levels of free vascular endothelial growth factor (165) (VEGF(165)) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): Results of a prospective cohort study with matched controls. Eur J Obstet Gynecol Reprod Biol 2001;96:196-201
24. Friedman CI, Seifer DB, Kennard EA, et al: Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril 1998;70: 836-839
25. Battaglia C, Genazzani AD, Regnani G, et al: Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 2000;74:809-812
26. Quintana R, Kopcow L, Marconi G, et al: Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulose cell apoptosis. Hum Reprod 2001;16:1818-0000
27. Tokuyama O, Nakamura Y, Muso A, et al: Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: A comparison of hMG, clomiphene citrate, and natural cycle. J Assist Reprod Genet 2002;19:19-23
28. Geva E, Amit A, Lessing JB, et al: Follicular fluid levels of vascular endothelial growth factor: Are they predictive markers for ovarian hyperstimulation syndrome? J Reprod Med 1999;44:91-96
29. D'Ambrogio G, Fasciani A, Monti M, et al: Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. Gynecol Endocrinol 1999;13:311-315
30. Manau D, Balasch J, Jimenez W, et al: Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: Relationship to ovarian response. Hum Reprod 2000;15:1295-1299
31. Benifla JL, Bringuier AF, Sifer C, et al: Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF. Hum Reprod 2001;16:1376-1381
32. Barroso G, Barrionuevo M, Rao P, et al: Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients. Fertil Steril 1999;72:1024-1026
33. Lee A, Christenson K, Stouffer RL, et al: Vascular endothelial growth factor in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 1997;68:305-311
34. Dorn C, Reinsberg J, Kupka M, et al: Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization. Arch Gynecol Obstet 2003;268:187-193
35. Unkila-Kallio L, Vuorela-Vepsalainen P, Tiitinen A, et al: No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program. Am J Reprod Immunol 2000;43:25-30
36. Krasnow JS, Berga SL, Guzick DS, et al: Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report. Fertil Steril 1996;65:552-555
37. Artini PG, Fasciani A, Monti M, et al: Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 1998;70:560-564
38. Ludwig M, Bauer O, Lopens A, et al: Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod 1998;13:30-32
39. Abramov Y, Barak V, Nisman B, et al: Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997;67:261-265
40. Aboulghar MA, Mansour RT, Serour GI, et al: Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 1999;87:81-85
41. Chen CD, Wu MY, Chen HF, et al: Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1999;72:286-292
42. Chen CD, Chen HF, Lu HF, et al: Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Hum Reprod 2002;15:1037-1042
43. Malamitsi-Puchner A, Sarandakou A, Baka SG, et al: Concentrations of angiogenic factors in follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: Association with oocyte maturity and fertilization. Fertil Steril 2001;76:98-101
44. Malamitsi-Puchner A, Sarandakou A, Baka S, et al: In vitro fertilization: Angiogenic, proliferative, and apoptotic factors in the follicular fluid. Ann N Y Acad Sci 2003;997:124-128
45. McElhinney B, Ardili J, Caldwell C, et al: Ovarian hyperstimulation syndrome and assisted reproductive technologies: Why some and not others? Hum Reprod 2002;17:1548-1553
46. Pellicer A, Garrido N, Albert C, et al: Cytokines in older patients undergoing in vitro fertilization: The relationship to the response to controlled ovarian hyperstimulation. J Assist Reprod Genet 1999;16:247-252
47. Moncayo HE, Penz-Koza A, Marth C, et al: Vascular endothelial growth factor in serum and in the follicular fluid of patients undergoing hormonal stimulation for in-vitro fertilization. Hum Reprod 1998;13:3310-3314
48. Webb NJ, Bottomley MJ, Watson CJ, et al: Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998;94:395-404